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ABSTRACT 
Background and purpose: Andrographolide, the major phytoconstituent of Andrographis 
paniculata, was previously shown by us to have activity against breast cancer. This led to 
synthesis of new andrographolide analogues to find compounds with better activity than the 
parent compound. Selected benzylidene derivatives were investigated for their mechanisms 
of action by studying their effects on the cell cycle progression and cell death. Experimental 
approach: Microculture tetrazolium, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) and sulphorhodamine B (SRB) assays were utilized in assessing the in vitro 
growth inhibition and cytotoxicity of compounds. Flow cytometry was used to analyse the 
cell cycle distribution of control and treated cells. CDK1 and CDK4 levels were determined 
by western blotting. Apoptotic cell death was assessed by fluorescence microscopy and flow 
cytometry. Key results: Compounds, in nanomolar to micromolar concentrations, exhibited 
growth inhibition and cytotoxicity in MCF-7(breast) and HCT-116 (colon) cancer cells. In 
the NCI screen, 3,19-(2-bromobenzylidene) andrographolide (SRJ09) and 3,19-(3-chloro-4-
fluorobenzylidene) andrographolide (SRJ23) showed greater cytotoxic potency and 
selectivity than andrographolide. SRJ09 and SRJ23 induced G1 arrest and apoptosis in MCF-
7 and HCT-116 cells, respectively. SRJ09 downregulated CDK4 but not CDK1 level in 
MCF-7 cells. Apoptosis induced by SRJ09 and SRJ23 in HCT-116 cells was confirmed by 
annexin V-FITC/PI flow cytometry analysis. Conclusion and implications: The new 
benzylidene derivatives of andrographolide are potential anticancer agents. SRJ09 emerged 
as the lead compound in this study, exhibiting anticancer activity by downregulating CDK4 
to promote a G1 phase cell cycle arrest, coupled with induction of apoptosis. 
  
Keyword: andrographolide derivatives, antitumour, cell cycle, G1 arrest, NCI cell lines, 
CDK-4, apoptosis, v-Src 
 
